Biogen | Продажи





Продажи Изменить Дата
AbbVie USD 16.62B 840M 2025-12
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
ALKERMES USD 394.2M 3.5M 2025-09
Amgen USD 9.9B 340M 2025-12
Bayer EUR 9.66B 1.08B 2025-09
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Gilead Sciences USD 7.93B 130M 2025-12
Incyte USD 1.51B 140M 2025-12
Merck USD 16.4B 880M 2025-12
Moderna USD 678M 342M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.3B 1.13B 2025-12
Sanofi EUR 12.2B 3.19B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
United Therapeutics USD 799.5M 900K 2025-09
Vertex Pharmaceuticals USD 3.19B 110M 2025-12


Biogen Продажи - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Feb 2026.